Closed
SectorHealthcare
108.31 3.78
24h
Min
101.67
Max
108.31
Income | -24M -31M |
---|---|
Sales | -9M 43M |
P/E Sector Avg | 47.016 63.778 |
EPS | 1.27 |
Profit margin | -72.615 |
Employees | 68 |
EBITDA | -33M -30M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +42.91% upside |
Next Earnings | 6 maj 2025 |
---|
Market Cap | 12M 2.1B |
---|---|
Previous open | 104.53 |
Previous close | 108.31 |
By Acuity
50%
50%
180 / 386 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 149.8 USD 42.91%
High 160 USD
Low 135 USD
Based on 6 Wall Street analysts offering 12 month price targets forLigand Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$